| MicroRNA: A signature for cancer progression BM Hussen, HJ Hidayat, A Salihi, DK Sabir, M Taheri, S Ghafouri-Fard Biomedicine & Pharmacotherapy 138, 111528, 2021 | 265 | 2021 |
| Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy MF Rasul, BM Hussen, A Salihi, BS Ismael, PJ Jalal, A Zanichelli, ... Molecular Cancer 21 (1), 1-30, 2022 | 134 | 2022 |
| Interplay between PI3K/AKT pathway and heart disorders S Ghafouri-Fard, A Khanbabapour Sasi, BM Hussen, H Shoorei, A Siddiq, ... Molecular biology reports 49 (10), 9767-9781, 2022 | 117 | 2022 |
| A review on the role of cyclin dependent kinases in cancers S Ghafouri-Fard, T Khoshbakht, BM Hussen, P Dong, N Gassler, M Taheri, ... Cancer Cell International 22 (1), 325, 2022 | 84 | 2022 |
| The critical roles of lncRNAs in the development of osteosarcoma. S Ghafouri-Fard, Z Shirvani-Farsani, BM Hussen, M Taheri Biomedicine & Pharmacotherapy= Biomedecine & Pharmacotherapie 135, 111217-111217, 2021 | 69 | 2021 |
| Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy BM Hussen, GSH Faraj, MF Rasul, HJ Hidayat, A Salihi, A Baniahmad, ... Cancer Cell International 22 (1), 323, 2022 | 68 | 2022 |
| The emerging roles of NGS in clinical oncology and personalized medicine BM Hussen, ST Abdullah, A Salihi, DK Sabir, KR Sidiq, MF Rasul, ... Pathology-Research and Practice 230, 153760, 2022 | 59 | 2022 |
| Interleukin-1 in obesity-related low-grade inflammation: From molecular mechanisms to therapeutic strategies M Ghanbari, SM Maragheh, A Aghazadeh, SR Mehrjuyan, BM Hussen, ... International immunopharmacology 96, 107765, 2021 | 59 | 2021 |
| Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges BM Hussen, MF Rasul, SR Abdullah, HJ Hidayat, GSH Faraj, FA Ali, ... Military Medical Research 10 (1), 32, 2023 | 58 | 2023 |
| A review on the role of mir-16-5p in the carcinogenesis S Ghafouri-Fard, T Khoshbakht, BM Hussen, ST Abdullah, M Taheri, ... Cancer cell international 22 (1), 342, 2022 | 58 | 2022 |
| The interaction between miRNAs/lncRNAs and Notch pathway in human disorders S Ghafouri-Fard, MC Glassy, A Abak, BM Hussen, V Niazi, M Taheri Biomedicine & Pharmacotherapy 138, 111496, 2021 | 56 | 2021 |
| LncRNA signature in colorectal cancer S Ghafouri-Fard, BM Hussen, A Gharebaghi, R Eghtedarian, M Taheri Pathology-Research and Practice 222, 153432, 2021 | 55 | 2021 |
| The interaction between miRNAs/lncRNAs and nuclear factor-κB (NF-κB) in human disorders S Ghafouri-Fard, A Abak, F Fattahi, BM Hussen, Z Bahroudi, H Shoorei, ... Biomedicine & Pharmacotherapy 138, 111519, 2021 | 52 | 2021 |
| The role of HPV gene expression and selected cellular MiRNAs in lung cancer development BM Hussen, G Ahmadi, H Marzban, MEF Azar, S Sorayyayi, R Karampour, ... Microbial pathogenesis 150, 104692, 2021 | 50 | 2021 |
| The prevalence of Helicobacter pylori among university students in Iraq BM Hussen, SS Qader, HF Ahmed, SH Ahmed Indian Journal of Science and Technology 6 (8), 5019-5023, 2013 | 48 | 2013 |
| Colorectal cancer cell-derived extracellular vesicles transfer miR-221-3p to promote endothelial cell angiogenesis via targeting suppressor of cytokine signaling 3 M Dokhanchi, K Pakravan, S Zareian, BM Hussen, M Farid, E Razmara, ... Life Sciences 285, 119937, 2021 | 46 | 2021 |
| Identification of a six‐microRNA signature as a potential diagnostic biomarker in breast cancer tissues M Mahmoudian, E Razmara, B Mahmud Hussen, M Simiyari, N Lotfizadeh, ... Journal of clinical laboratory analysis 35 (11), e24010, 2021 | 45 | 2021 |
| MicroRNA signature in liver cancer S Ghafouri-Fard, KH Tamizkar, BM Hussen, M Taheri Pathology-Research and Practice 219, 153369, 2021 | 45 | 2021 |
| A review on the role of miR-1246 in the pathoetiology of different cancers S Ghafouri-Fard, T Khoshbakht, BM Hussen, M Taheri, M Samadian Frontiers in molecular biosciences 8, 771835, 2022 | 44 | 2022 |
| Hormonal regulation of telomerase activity and hTERT expression in steroid-regulated tissues and cancer M Taheri, S Ghafouri-Fard, S Najafi, J Kallenbach, E Keramatfar, ... Cancer cell international 22 (1), 258, 2022 | 43 | 2022 |
Mohammad TaheriInstitute of Human Genetics, Jena, GermanyPatvirtintas el. paštas uni-jena.de
